Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms
September 04 2020, 08:00
The five sites will test AZD1222, the vaccine candidate currently being developed by AstraZeneca.
The five sites will test AZD1222, the vaccine candidate currently being developed by AstraZeneca.
Source:
FOX News